| Date Filed | Type | Description |
| 06/02/2023 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 19,000 options to buy
@ $4.67, valued at
$88.7k
Granted 4,500 restricted stock units
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 36,000 options to buy
@ $3.96, valued at
$142.6k
|
|
| 05/24/2022 |
3
| HEIDEN WILLIAM K (Director) has filed a Form 3 on MACROGENICS INC |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 24,500 options to buy
@ $10.54, valued at
$258.2k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 13,000 options to buy
@ $20.25, valued at
$263.3k
|
|
| 05/09/2019 |
4
| HEIDEN WILLIAM K (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Bought 10,000 shares
@ $10.7, valued at
$107k
|
|
| 03/05/2019 |
4
| HEIDEN WILLIAM K (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 3,535 shares
@ $14.76, valued at
$52.2k
Paid exercise price by delivering 4,467 shares
@ $14.76, valued at
$65.9k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2018 |
4
| HEIDEN WILLIAM K (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 5,000 shares
@ $25, valued at
$125k
|
|
| 06/18/2018 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 1,500 shares
@ $0
Granted 5,000 options to buy
@ $45.65, valued at
$228.3k
|
|
| 06/05/2018 |
4
| HEIDEN WILLIAM K (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 20,000 shares
@ $25, valued at
$500k
|
|
| 03/06/2018 |
4
| HEIDEN WILLIAM K (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 45,500 shares
@ $0
Paid exercise price by delivering 10,546 shares
@ $21, valued at
$221.5k
Granted 100,000 options to buy
@ $21, valued at
$2.1M
|
|
| 06/12/2017 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 21,500 options to buy
@ $13.2, valued at
$283.8k
|
|
| 05/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc. |
| 05/17/2016 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 11,812 shares
@ $18.27, valued at
$215.8k
|
|
| 03/01/2016 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 10,649 shares
@ $27.01, valued at
$287.6k
Paid exercise price by delivering 4,070 shares
@ $27.01, valued at
$109.9k
Paid exercise price by delivering 1,843 shares
@ $27.01, valued at
$49.8k
Paid exercise price by delivering 1,701 shares
@ $26.28, valued at
$44.7k
Granted 36,000 shares
@ $0
Granted 85,000 options to buy
@ $25.18, valued at
$2.1M
|
|
| 01/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/25/2015 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 15,500 options to buy
@ $34.98, valued at
$542.2k
|
|
| 10/02/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 2,000 shares
@ $39.69, valued at
$79.4k
|
|
| 09/02/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 2,000 shares
@ $61.19, valued at
$122.4k
|
|
| 08/05/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 2,000 shares
@ $64.53, valued at
$129.1k
|
|
| 07/17/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 20,000 shares
@ $75, valued at
$1.5M
Exercised 20,000 options to buy
@ $12.99, valued at
$259.8k
|
|
| 07/02/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 2,000 shares
@ $69.41, valued at
$138.8k
|
|
| 06/08/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 6,875 shares
@ $68.14, valued at
$468.5k
Sold 6,642 shares
@ $68.9, valued at
$457.6k
Sold 36,550 shares
@ $69.77, valued at
$2.6M
Sold 4,680 shares
@ $70.69, valued at
$330.8k
Sold 12,128 shares
@ $71.52, valued at
$867.4k
Exercised 60,000 options to buy
@ $12.99, valued at
$779.4k
|
|
| 06/04/2015 |
4
| HEIDEN WILLIAM K (CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 11,378 shares
@ $67.77, valued at
$771.1k
|
|
| 03/05/2015 |
4
| HEIDEN WILLIAM K (President and CEO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 2,474 shares
@ $49.7, valued at
$123k
|
|
|